NCT05695352: A trial that was reported late by InnovaGyn, Inc.
This trial has reported, although it was 122 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT05695352 |
|---|---|
| Title | A Phase II Study to Evaluate the Delay in Ovulation Following Oral Levonorgestrel Plus Meloxicam Compared to Placebo in Normal Menstruating Women |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 28, 2022 |
| Completion date | Nov. 30, 2024 |
| Required reporting date | Nov. 30, 2025, midnight |
| Actual reporting date | April 1, 2026 |
| Date last checked at ClinicalTrials.gov | Oct. 21, 2026 |
| Days late | 122 |